The economic value of mismatch repair–guided immunotherapy in endometrial cancer: companion testing and patient selection

Sihan Jing, Yuan He, Yang Liu

Open source

DOI
10.3389/fmed.2026.1951624
Published
2026-09-09
Container
Frontiers in Medicine
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1951624,
  title = {The economic value of mismatch repair–guided immunotherapy in endometrial cancer: companion testing and patient selection},
  author = {Sihan Jing and Yuan He and Yang Liu},
  year = {2026},
  journal = {Frontiers in Medicine},
  doi = {10.3389/fmed.2026.1951624},
  url = {https://doi.org/10.3389/fmed.2026.1951624}
}

RIS

TY  - JOUR
TI  - The economic value of mismatch repair–guided immunotherapy in endometrial cancer: companion testing and patient selection
AU  - Sihan Jing
AU  - Yuan He
AU  - Yang Liu
PY  - 2026
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2026.1951624
UR  - https://doi.org/10.3389/fmed.2026.1951624
ER  - 

APA

Jing, S., He, Y., & Liu, Y. (2026). The economic value of mismatch repair–guided immunotherapy in endometrial cancer: companion testing and patient selection. Frontiers in Medicine. https://doi.org/10.3389/fmed.2026.1951624

Source records